Aurora Cannabis Inc. (NYSE:ACB) Receives Average Recommendation of “Hold” from Analysts

Shares of Aurora Cannabis Inc. (NYSE:ACBGet Rating) have received an average rating of “Hold” from the eight brokerages that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $5.18.

ACB has been the topic of a number of recent analyst reports. Cantor Fitzgerald raised Aurora Cannabis from a “neutral” rating to an “overweight” rating in a research report on Friday, June 24th. Stifel Nicolaus raised Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 target price on the stock in a research report on Monday, June 6th. Finally, CIBC lowered their price target on Aurora Cannabis from C$6.50 to C$3.75 in a report on Monday, May 16th.

Aurora Cannabis Stock Down 1.3 %

Shares of Aurora Cannabis stock opened at $1.50 on Friday. The stock’s fifty day moving average is $1.43 and its 200-day moving average is $2.83. The firm has a market capitalization of $340.20 million, a PE ratio of -0.32 and a beta of 2.74. The company has a quick ratio of 4.76, a current ratio of 5.85 and a debt-to-equity ratio of 0.32. Aurora Cannabis has a 12-month low of $1.21 and a 12-month high of $8.69.

Aurora Cannabis (NYSE:ACBGet Rating) last announced its earnings results on Thursday, May 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.88). The company had revenue of $39.82 million for the quarter, compared to analyst estimates of $40.58 million. Aurora Cannabis had a negative return on equity of 25.80% and a negative net margin of 542.50%. Equities analysts anticipate that Aurora Cannabis will post -1.65 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. TD Asset Management Inc. grew its stake in Aurora Cannabis by 24.4% in the second quarter. TD Asset Management Inc. now owns 703,781 shares of the company’s stock valued at $927,000 after purchasing an additional 137,999 shares in the last quarter. Capital Wealth Alliance LLC purchased a new position in Aurora Cannabis in the second quarter valued at about $165,000. CWM LLC grew its stake in Aurora Cannabis by 1,370.0% in the second quarter. CWM LLC now owns 41,776 shares of the company’s stock valued at $55,000 after purchasing an additional 38,934 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Aurora Cannabis by 11.3% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,798,034 shares of the company’s stock worth $2,373,000 after acquiring an additional 182,139 shares in the last quarter. Finally, Exchange Traded Concepts LLC bought a new stake in shares of Aurora Cannabis during the 2nd quarter worth about $34,000. Hedge funds and other institutional investors own 15.47% of the company’s stock.

Aurora Cannabis Company Profile

(Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Recommended Stories

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Want More Great Investing Ideas?

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.